Report Description Table of Contents Industry Report and Statistics (Facts & Figures) - Sales Volume, ASP & Number of Procedure Conducted by Type & Application The global cardiac pacemaker market will witness a robust CAGR of 3.68%, valued at $3.93 billion (1.40 million units) in 2021, expected to appreciate and reach $7.21 billion by 2030, confirms Strategic Market Research. Market Drivers - The Continuous Rise of CVDs, and Cardiac Surgeries Worldwide The continuously rising incidences of CVDs (cardiovascular diseases) is one of the major factors that is propelling the overall growth of the cardiac pacemaker market. According to the AHA (American Heart Association), CVDs caused 868,662 deaths in 2017. In 2018, in the U.S, CHD (coronary heart disease) was the primary cause of death (42.1%), followed by stroke (17.0%), high BP (11.0%), Cardiac failure (9.6%), arterial diseases (2.9%), and other CVDs (17.4%). Due to the increase of CVDs, governments worldwide have increased their expenditure on Cardiac Disease Management (like cardiac surgeries, cardiac resynchronization therapy, etc.), which is highly fuelling the global market growth. According to Lifespan Health System, approximately 500,000 open-heart surgeries are conducted annually in the United States, like coronary artery bypass and several other complex aortic surgeries. Also, in a new study by SMR, in the United States, more than 900,000 total cardiac surgeries are performed each year. Apart from cardiac disease management, the introduction of various kinds of pacemakers like acid pacemaker, iPhone 12 pacemaker, Micra leadless pacemaker, st Jude medical pacemaker, single chamber pacemaker, Dual-chamber pacemaker, Biventricular pacemaker, Abbott pacemaker (Assurity and Enduring), and processes such as Electrocardiogram, Holter monitoring, and Echocardiogram, are highly facilitating the overall market growth. Further, the highly favorable government policies and the introduction of technologically upgraded pacemakers (MRI safe pacemakers and leadless pacemakers) are highly stimulating the overall market growth. Restraints - Rise in Pacemaker Infections The increase of various pacemaker infections, bradycardia, blood clots, air leakage, and Twiddler’s Syndrome are some of the factors that are highly restraining the overall growth of this market. Opportunities - Production of High-End Pacemakers Nowadays, global organizations are entirely focused on manufacturing high-end pacemakers (biventricular pacemakers) that comprehensively meet all the patient’s requirements, thereby catering to customized care. These new innovations are widely enhancing workflow accuracy and facilitating error reduction rates, thereby creating ample opportunities for the market in the future. Cardiac Pacemaker Market Analysis Of Different Segments Covered in the Report Based on Product Outlook Implantable Cardiac Pacemakers Dual Chamber Single Chamber Biventricular Chamber External pacemakers Based on Type Conventional Pacemakers MRI Compatible Pacemakers Based on Applications Arrhythmias Heart Blockage Atrial Fibrillation Long QT Syndrome Congestive Cardiac Failure Others Based on End-User Hospitals & Cardiac Centers ASCs (Ambulatory Surgical Centers) Others Regional Coverage Analysis North America United States Mexico Canada Rest of North America Europe Switzerland Russia France Germany U.K Finland Turkey Netherlands Belgium Spain Italy Rest of Europe Asia Pacific China India Indonesia South Korea Thailand Japan Singapore Malaysia Philippines Australia New Zealand Rest of APAC LAMEA Brazil Saudi Arabia Uruguay Argentina Rest of LAMEA Based on Product Outlook, the ‘Implantable Cardiac Pacemakers’market dominated with an overall share of approximately 63.75% in 2020. The rise in the adoption of these devices for arrhythmias, treatment of cardiac failure, and ongoing clinical trial processes are the key factors driving this segment's overall growth. Based on Type, the ‘Conventional Pacemakers’ held the largest market share of nearly 52.37% of the entire market. Continuous technological upgrades, small size, and high affordability are the major factors driving the segment growth. On the other hand, the ‘MRI Compatible Pacemakers’ held the fastest growth rate throughout the forecasted period. In 2018, According to Mayo Foundation for Medical Education and Research, approximately 78.36% of patients with an implantable pacemaker needed an MRI during their lifetimes. Hence, the segment witnessed the highest rate of growth. Based on Applications, the ‘Arrhythmias’ segment dominated the market with a total market share of approximately 39.21 percent in 2020. Factors such as excessive alcohol consumption, obesity, smoking, and other lifestyle disorders are contributing to the increase in the risk of cardiac arrhythmia, which in turn is driving the overall growth of this segment. Based on End-User, the ‘Hospitals & Cardiac Centers’ significantly dominated the market with a total revenue share of approximately 62.37% during the estimated period. The rise of cardiac patient admissions and excellent reimbursement facilities during the surgeries are the factors that are fuelling the growth of this segment. According to AHA (American Heart Association), the total number of cardiac patients is expected to rise approximately by 23.6 Mn by 2030. Based on Region, North America significantly held the largest cardiac pacemaker market share of nearly 43.78% throughout the estimated period. The pacemaker market in the USA is expected to witness a healthy CAGR throughout the forecasted period. A continuous increase in the geriatric population with cardiac problems, rapid technological advancements (such as Bluetooth-enabled pacemakers, MRI-compatible pacemakers, etc.), and improved regulatory approvals are stimulating the market growth in this region. Asia Pacific held the fastest growth rate during the forecasted period with a robust CAGR. The increase in government funding in the healthcare sector, especially for cardiac diagnosis and treatment in countries like India, Japan, and China, is also accelerating the growth of this segment. Global Cardiac Pacemaker Market Competitive Landscape Analysis An overall competitive landscape analysis is essential for accumulating accurate information regarding the crucial competitors in the global market. The comparison is performed based on total revenue generation, cardiac pacemaker market initiatives, investment in R&D, a 360-degree company overview, market potential, company strengths and weaknesses, company financials, global presence, production sites and facilities, production capacity, etc. Boston Scientific Corporation Medtronic Zoll Medical Corporation MicroPort Scientific Corporation Cook Medical BIOTRONIK MEDICO SpA Pacetronix Oscor Inc. Osypka Medical GmbH Lepu Medical LivaNova Pacetronix MEDICO Osypka Medical Cardiac Pacemaker Market Report Coverage Report Attribute Details Forecast Period 2021 - 2030 The market size value in 2021 USD 3.93 billion The revenue forecast in 2030 USD 7.21 billion Growth rate CAGR of approximately 3.68 % The base year for estimation 2021 Historical data 2017 – 2020 Unit USD Billion, CAGR (2021 - 2030) Segmentation Based on Product Outlook, Based on Type, Based on Applications, Based on End-User, Based on Regions: Based on Product Outlook Implantable Cardiac Pacemakers (Dual Chamber, Single Chamber, Biventricular Chamber), External pacemakers Based on Type Conventional Pacemakers, MRI Compatible Pacemakers Based on Applications Arrhythmias (Heart Blockage, Atrial Fibrillation, Long QT Syndrome), Congestive Cardiac Failure, Others Based on End-User Hospitals & Cardiac Centers, ASCs (Ambulatory Surgical Centers), Others Based on Regions North America, Asia-Pacific, Europe, LAMEA Country Scope United States of America, Mexico, United Arab Emirates, United Kingdom, Germany, France, Canada, China, India, Japan, South Korea, Brazil, Argentina, Saudi Arabia, South Africa Company Usability Profiles Boston Scientific Corporation, Medtronic, Zoll Medical Corporation, MicroPort Scientific Corporation, Cook Medical, BIOTRONIK, MEDICO SpA, Pacetronix, Oscor Inc., Osypka Medical GmbH, Lepu Medical, LivaNova, Pacetronix, MEDICO, Osypka Medical Recent Developments On August 2022, Cornell University scientists tested their newly developed pacemaker on mini-donkey suffering from severe cardiac disease to detect its efficacy in managing fatal heart conditions. Veterinarians conducted an EEG/echocardiography & installed an ECG on the donkey to record its heart beating. It showed highly positive results, and within a month or two, the donkey's condition gradually improved. Cornell University announced that its new pacemaker would receive FDA approval within the next month for its launching in the market. In May 2020, BIOTRONIK launched a home monitoring system for providing safe and cost-effective management for patients with pacemakers. On January 2020, Medtronic announced FDA approval for its product Micra AV, the world’s smallest 2nd generation wireless pacemaker directly implanted into the heart. On April 2018, MicroPort completed the acquisition of the Cardiac Rhythm Management Business from LivaNova. This would highly improvise its market penetration across the globe. Key Devices that Leading Market Players Develop PRODUCT NAME FUNCTION COMPANY ACCOLADE Pacing Systems Provides the best options for MRI programmability. Its automatic features support AF detection, lead checks, and wireless remote monitoring in patient management, boosting the Boston scientific pacemaker market size and share. Boston Scientific Corporation AZURE PACEMAKER Provides exclusive algorithms for accurately detecting and reducing the risk of atrial fibrillation, thereby stimulating the Medtronic pacemaker market share. Medtronic PACE 300 It is the world’s first 3-chambered temporary cardiac pacemaker that is effectively designed to be used with the cardiac pacing lead systems for temporary atrial pacing. It is also implemented for therapeutic or prophylactic purposes. Osypka Medical Frequently Asked Question About This Report How big is the cardiac pacemaker market size? The global cardiac pacemaker market size was $3.93 billion in 2021 and is predicted to reach $7.21 billion by 2030, with a CAGR of 3.68%. Who are the essential players of the market? The most vital players of the market are Boston Scientific Corporation, Medtronic, Zoll Medical Corporation, MicroPort Scientific Corporation, Cook Medical, BIOTRONIK, MEDICO SpA, Pacetronix, Oscor Inc, Osypka Medical GmbH, Lepu Medical, LivaNova, Pacetronix, MEDICO and Osypka Medical. Which is the most dominating End-User segment of the market? Based on End-User, the Hospitals & Cardiac Centers significantly dominated the market with a total revenue share of approximately 62.37% during the estimated period What is the cardiac pacemaker market growth? The global cardiac pacemaker market is expected to grow at a compound annual growth rate (CAGR) of 3.68 % from 2021 to 2030 to reach USD $ 7.21 billion by 2030. Which is the most dominant product outlook in the global market? Based on Product Outlook, the Implantable Pacemakers dominated the market with an overall share of approximately 63.75% in 2020. Sources https://www.heart.org/-/media/phd-files-2/science-news/2/2021-heart-and-stroke-stat-update/2021_heart_disease_and_stroke_statistics_update_fact_sheet_at_a_glance.pdf https://news.biotronik.com/home-monitoring-shown-to-safely-and-efficiently-replace-face-to-face-follow-ups-for-pacemaker-patients/ 1. Introduction 1.1. Study Objective 1.2. Market Definition 1.3. Study Scope 1.3.1. Markets Covered 1.3.2. Geographic Scope 1.3.3. Years Considered 1.3.4. Stakeholders 2. Research Methodology 2.1. Data Procurement 2.2. Paid Database 2.2.1. Secondary Data 2.2.1.1. Key Secondary sources 2.2.2. Primary Data 2.2.2.1 Primary sources 2.2.2.2. Key industry insights 2.2.2.3. Primary interviews with experts 2.2.2.4. Key primary respondent list 2.3. Market Size Estimation 2.4. Bottom-Up and Top-Down Approaches 2.4.1. Bottom-Up Approach 2.4.1.1. Approach for arriving at market size by bottom-up analysis 2.4.2. Top-Down Approach 2.4.2.1. Approach for Capturing Market Size by Top-Down Analysis 2.5. Market Breakdown and Data Triangulation 2.6. Research Methodology 2.7. Risk Assessment 3. Executive Summary 3.1 Post-Covid-19 3.1.1 Actual Scenario 3.1.2 Pessimistic Scenario 3.1.3 Optimistic Scenario 3.1.4 Market Summary 4. Industry Outlook 4.1 Market Snapshot 4.2 Global Cardiac Pacemaker Market 4.2.1 Global market, 2021 – 2030 (USD Million) 4.3 Regional Business Analysis 4.3.1 Global market, by region, 2021 - 2030 (USD Million) 4.4 By Product Business Analysis 4.4.1 Global market, By Product, 2021 - 2030 (USD Million) 4.5 By Type Business Analysis 4.5.1 Global market, By Type, 2021 - 2030 (USD Million) 4.6 Application Business Analysis 4.6.1 Global market, By Application, 2021 - 2030 (USD Million) 4.6 End-User Business Analysis 4.6.1 Global market, By End-User, 2021 - 2030 (USD Million) 4.7 Value Chain Analysis 4.8 Market Variable Analysis 4.8.1 Market Drivers Analysis 4.8.2 Market Restraints Analysis 4.9 Business Environment Analysis Tool 4.9.1 market PEST analysis 4.9.2 market Porter’s analysis 4.10 Penetration & Growth Prospect Mapping 5. Market Dynamics 5.1. Introduction 5.2. Market Dynamics 5.2.1. Drivers 5.2.2. Restraints 5.2.3. Opportunities 5.2.4. Challenges 5.3. Impact of Covid-19 On Market 5.4. Value Chain Analysis 5.5. Ecosystem 5.6. Patent Analysis 5.7. Trade Analysis 5.8. Tariff Analysis 5.9. Case Study Analysis 5.10. Porter’s Five Forces Analysis 5.10.1 Threat of New Entrants 5.10.2 Threat of Substitutes 5.10.3 Bargaining Power of Buyers 5.10.4 Bargaining Power of Suppliers 5.10.5 Degree of Competition 5.11. Product Analysis 5.11.1. Trends in Product (2014-2021) 5.11.2. Trends in Product (2021-2030) 5.12. Pricing Analysis 5.12.1. Average Price Trend Analysis (By region, By Countries) 6. Competitive & Vendor Landscape 6.1. Company Market Share Analysis 6.2. Manufacturers Manufacturing Sites, Area Served, Product Type 6.3. Market Competitive Situation and Trends 6.4. Manufacturers Mergers & Acquisitions, Expansion Plans 7. Global Market: By Product Segment Analysis 7.1. Introduction 7.2. Sales Volume & Revenue Analysis (2021-2030) 7.3. Implantable Cardiac Pacemakers 7.3.1. Implantable Cardiac Pacemakers market, 2021 - 2030 (USD Million) 7.3.1.1 Dual Chamber market, 2021 - 2030 (USD Million) 7.3.1.2 Single Chamber market, 2021 - 2030 (USD Million) 7.3.1.3 Biventricular Chamber market, 2021 - 2030 (USD Million) 7.4. External pacemakers 7.4.1. External pacemakers market, 2021 - 2030 (USD Million) 8. Global Market: By Type Segment Analysis 8.1. Introduction 8.2. Sales Volume & Revenue Analysis (2021-2030) 8.3. Conventional Pacemakers 8.3.1. Conventional Pacemakers market, 2021 - 2030 (USD Million) 8.4. MRI Compatible Pacemakers 8.4.1. MRI Compatible Pacemakers market, 2021 - 2030 (USD Million) 9. Global Market: By Application Segment Analysis 9.1. Introduction 9.2. Sales Volume & Revenue Analysis (2021-2030) 9.3. Arrhythmias 9.3.1. Arrhythmias market, 2021 - 2030 (USD Million) 9.3.1.1 Heart Blockage market, 2021 - 2030 (USD Million) 9.3.1.2 Atrial Fibrillation market, 2021 - 2030 (USD Million) 9.3.1.3 Long QT Syndrome market, 2021 - 2030 (USD Million) 9.4. Congestive Cardiac Failure 9.4.1. Congestive Cardiac Failure market, 2021 - 2030 (USD Million) 9.5 Others 9.5.1 Others market, 2021 - 2030 (USD Million) 10. Global Market: By End-User Segment Analysis 10.1. Introduction 10.2. Sales Volume & Revenue Analysis (2021-2030) 10.3. Hospitals & Cardiac Centers 10.3.1. Hospitals & Cardiac Centers market, 2021 - 2030 (USD Million) 10.4. ASCs (Ambulatory Surgical Centers) 10.4.1. ASCs (Ambulatory Surgical Centers) market, 2021 - 2030 (USD Million) 10.5 Others 10.5.1 Others market, 2021 - 2030 (USD Million) 11. Global Market: Regional Outlook 11.1 North America 11.1.1. North America market, By Product, 2021 - 2030 (USD Million) 11.1.2. North America market, By Type, 2021 - 2030 (USD Million) 11.1.3. North America market, by Application, 2021 - 2030 (USD Million) 11.1.4. North America market, By End-User, 2021 - 2030 (USD Million) 11.1.5. North America market, by Country, 2021 - 2030 (USD Million) 11.1.4.1. U.S. 11.1.4.1.1. U.S. market, By Product, 2021 - 2030 (USD Million) 11.1.4.1.2. U.S. market, By Type, 2021 - 2030 (USD Million) 11.1.4.1.3. U.S. market, by Application, 2021 - 2030 (USD Million) 11.1.4.2. Canada 11.1.4.2.1. Canada market, By Product, 2021 - 2030 (USD Million) 11.1.4.2.2. Canada market, By Type, 2021 - 2030 (USD Million) 11.1.4.2.3. Canada market, by Application, 2021 - 2030 (USD Million) 11.2. Europe 11.2.1. Europe market, By Product, 2021 - 2030 (USD Million) 11.2.1. Europe market, by By End-User, 2021 - 2030 (USD Million) 11.2.2. Europe market, By Type, 2021 - 2030 (USD Million) 11.2.3. Europe market, by Application, 2021 - 2030 (USD Million) 11.2.4. Europe market, by country, 2021 - 2030 (USD Million) 11.2.4.1 U.K. 11.2.4.1.1. U.K. market, By Product, 2021 - 2030 (USD Million) 11.2.4.1.2. U.K. market, By Type, 2021 - 2030 (USD Million) 11.2.4.1.3. U.K. market, by Application, 2021 - 2030 (USD Million) 11.2.4.2. Germany 11.2.4.2.1. Germany market, By Product, 2021 - 2030 (USD Million) 11.2.4.2.2. Germany market, By Type, 2021 - 2030 (USD Million) 11.2.4.2.3. Germany market, by Application, 2021 - 2030 (USD Million) 11.2.4.3. France 11.2.4.3.1. France market, By Product, 2021 - 2030 (USD Million) 11.2.4.3.2. France market, By Type, 2021 - 2030 (USD Million) 11.2.4.3.3. France market, by Application, 2021 - 2030 (USD Million) 11.2.4.4. Rest of Europe 11.2.4.4.1. Rest of Europe market, By Product, 2021 - 2030 (USD Million) 11.2.4.4.2. Rest of Europe market, By Type, 2021 - 2030 (USD Million) 11.2.4.4.3. Rest of Europe market, by Application, 2021 - 2030 (USD Million) 11.3. Asia Pacific 11.3.1. Asia Pacific market, By Product, 2021 - 2030 (USD Million) 11.3.1. Asia Pacific market, By End-User, 2021 - 2030 (USD Million) 11.3.2. Asia Pacific market, By Type, 2021 - 2030 (USD Million) 11.3.3. Asia Pacific market, by Application, 2021 - 2030 (USD Million) 11.3.4. Asia Pacific market, by country, 2021 - 2030 (USD Million) 11.3.4.1. China 11.3.4.1.1. China market, By Product, 2021 - 2030 (USD Million) 11.3.4.1.2. China market, By Type, 2021 - 2030 (USD Million) 11.3.4.1.3. China market, by Application, 2021 - 2030 (USD Million) 11.3.4.2. India 11.3.4.2.1. India market, By Product, 2021 - 2030 (USD Million) 11.3.4.2.2. India market, By Type, 2021 - 2030 (USD Million) 11.3.4.2.3. India market, by Application, 2021 - 2030 (USD Million) 11.3.4.3. Japan 11.3.4.3.1. Japan market, By Product, 2021 - 2030 (USD Million) 11.3.4.3.2. Japan market, By Type, 2021 - 2030 (USD Million) 11.3.4.3.3. Japan market, by Application, 2021 - 2030 (USD Million) 11.3.4.4. South Korea 11.3.4.4.1. South Korea market, By Product, 2021 - 2030 (USD Million) 11.3.4.4.2. South Korea market, By Type, 2021 - 2030 (USD Million) 11.3.4.4.3. South Korea market, by Application, 2021 - 2030 (USD Million) 11.3.4.5. Rest of ASIA PACIFIC 11.3.4.5.1. Rest of ASIA PACIFIC market, By Product, 2021 - 2030 (USD Million) 11.3.4.5.2. Rest of ASIA PACIFIC market, By Type, 2021 - 2030 (USD Million) 11.3.4.5.3. Rest of ASIA PACIFIC market, by Application, 2021 - 2030 (USD Million) 11.4. Latin America 11.4.1. Latin America market, By Product, 2021 - 2030 (USD Million) 11.4.2. Latin America market, By Type, 2021 - 2030 (USD Million) 11.4.3. Latin America market, by Application, 2021 - 2030 (USD Million) 11.4.4. Latin America market, by country, 2021 - 2030 (USD Million) 11.4.4.1. Brazil 11.4.4.1.1. Brazil market, By Product, 2021 - 2030 (USD Million) 11.4.4.1.2. Brazil market, By Type, 2021 - 2030 (USD Million) 11.4.4.1.3. Brazil market, by Application, 2021 - 2030 (USD Million) 11.4.4.2. Mexico 11.4.4.2.1. Mexico market, By Product, 2021 - 2030 (USD Million) 11.4.4.2.2. Mexico market, By Type, 2021 - 2030 (USD Million) 11.4.4.2.3. Mexico market, by Application, 2021 - 2030 (USD Million) 11.4.4.3. Rest of the Latin America 11.4.4.3.1. Rest of the Latin America market, By Product, 2021 - 2030 (USD Million) 11.4.4.3.2. Rest of the Latin America market, By Type, 2021 - 2030 (USD Million) 11.4.4.3.3. Rest of the Latin America market, by Application, 2021 - 2030 (USD Million) 11.5. MEA 11.5.1. MEA market, By Product, 2021 - 2030 (USD Million) 11.5.2. MEA market, By Type, 2021 - 2030 (USD Million) 11.5.3. MEA market, by Application, 2021 - 2030 (USD Million) 11.5.4. MEA market, By End-User, 2021 - 2030 (USD Million) 12. Competitive Landscape 12.1 Boston Scientific Corporation. 12.1.1. Company overview 12.1.2. Financial performance 12.1.3. Product Portfolio Analysis 12.1.4. Business Strategy & Recent Development 12.2. Medtronic. 12.2.1. Company overview 12.2.2. Financial performance 12.2.3. Product Portfolio Analysis 12.2.4. Business Strategy & Recent Development 12.3. Zoll Medical Corporation 12.3.1. Company overview 12.3.2. Financial performance 12.3.3. Product Portfolio Analysis 12.3.4. Business Strategy & Recent Development 12.4. MicroPort Scientific Corporation. 12.4.1. Company overview 12.4.2. Financial performance 12.4.3. Product Portfolio Analysis 12.4.4. Business Strategy & Recent Development 12.5. Cook Medical 12.5.1. Company overview 12.5.2. Financial performance 12.5.3. Product Portfolio Analysis 12.5.4. Business Strategy & Recent Development 12.6. BIOTRONIK. 12.6.1. Company overview 12.6.2. Financial performance 12.6.3. Product Portfolio Analysis 12.6.4. Business Strategy & Recent Development 12.7. MEDICO SpA 12.7.1. Company overview 12.7.2. Financial performance 12.7.3. Product Portfolio Analysis 12.7.4. Business Strategy & Recent Development 12.8. Pacetronix. 12.8.1. Company overview 12.8.2. Financial performance 12.8.3. Product Portfolio Analysis 12.8.4. Business Strategy & Recent Development 12.9. Oscor Inc. 12.9.1. Company overview 12.9.2. Financial performance 12.9.3. Product Portfolio Analysis 11.9.4. Business Strategy & Recent Development 12.10. Osypka Medical GmbH. 12.10.1. Company overview 12.10.2. Financial performance 12.10.3. Product Portfolio Analysis 12.10.4. Business Strategy & Recent Development 12.11. Lepu Medical. 12.11.1. Company overview 12.11.2. Financial performance 12.11.3. Product Portfolio Analysis 12.11.4. Business Strategy & Recent Development 12.12. LivaNova. 12.12.1. Company overview 12.12.2. Financial performance 12.12.3. Product Portfolio Analysis 12.12.4. Business Strategy & Recent Development 12.13. Pacetronix 12.13.1. Company overview 12.13.2. Financial performance 12.13.3. Product Portfolio Analysis 12.13.4. Business Strategy & Recent Development 12.14. MEDICO. 12.14.1. Company overview 12.14.2. Financial performance 12.14.3. Product Portfolio Analysis 12.14.4. Business Strategy & Recent Development 12.15. Osypka Medical. 12.15.1. Company overview 12.15.2. Financial performance 12.15.3. Product Portfolio Analysis 12.15.4. Business Strategy & Recent Development List of Tables (68 Tables) TABLE 1. MARKET, By Product, 2021-2030 (USD Million) TABLE 2. MARKET FOR Implantable Cardiac Pacemakers, BY REGION, 2021-2030 (USD Million) TABLE 3. MARKET FOR Dual Chamber, BY REGION, 2021-2030 (USD Million) TABLE 4. MARKET FOR Single Chamber, BY REGION, 2021-2030 (USD Million) TABLE 5. MARKET FOR Biventricular Chamber, BY REGION, 2021-2030 (USD Million) TABLE 6. MARKET FOR External pacemakers, BY REGION, 2021-2030 (USD Million) TABLE 8. MARKET, By Type, 2021-2030 (USD Million) TABLE 9. MARKET FOR Conventional Pacemakers, BY REGION, 2021-2030 (USD Million) TABLE 10. MARKET FOR MRI Compatible Pacemakers, BY REGION, 2021-2030 (USD Million) TABLE 11. MARKET, BY APPLICATION, 2021-2030 (USD Million) TABLE 12. MARKET FOR Arrhythmias, BY REGION, 2021-2030 (USD Million) TABLE 13. MARKET FOR Heart Blockage, BY REGION, 2021-2030 (USD Million) TABLE 14. MARKET FOR Atrial Fibrillationg, BY REGION, 2021-2030 (USD Million) TABLE 15. MARKET FOR Long QT Syndrome, BY REGION, 2021-2030 (USD Million) TABLE 16. MARKET FOR Congestive Cardiac Failure, BY REGION, 2021-2030 (USD Million) TABLE 17. MARKET FOR Others, BY REGION, 2021-2030 (USD Million) TABLE 18. MARKET, By End-user, 2021-2030 (USD Million) TABLE 19. MARKET FOR Hospitals & Cardiac Centers, BY REGION, 2021-2030 (USD Million) TABLE 20. MARKET FOR ASCs (Ambulatory Surgical Centers), BY REGION, 2021-2030 (USD Million) TABLE 21. MARKET FOR Others, BY REGION, 2021-2030 (USD Million) TABLE 22. MARKET, BY REGION, 2021-2030 (USD Million) TABLE 23. NORTH AMERICA MARKET, BY COUNTRY, 2021-2030 (USD Million) TABLE 24. NORTH AMERICA MARKET, By Product, 2021-2030 (USD Million) TABLE 25. NORTH AMERICA MARKET, By Type, 2021-2030 (USD Million) TABLE 26. NORTH AMERICA MARKET, BY APPLICATION, 2021-2030 (USD Million) TABLE 27. EUROPE MARKET, BY COUNTRY, 2021-2030 (USD Million) TABLE 28. EUROPE MARKET, By Product, 2021-2030 (USD Million) TABLE 29. EUROPE MARKET, By Type, 2021-2030 (USD Million) TABLE 30. EUROPE MARKET, BY APPLICATION, 2021-2030 (USD Million) TABLE 31. ASIA-PACIFIC MARKET, BY COUNTRY, 2021-2030 (USD Million) TABLE 32. ASIA-PACIFIC MARKET, By Product, 2021-2030 (USD Million) TABLE 33. ASIA-PACIFIC MARKET, By Type, 2021-2030 (USD Million) TABLE 34. ASIA-PACIFIC MARKET, BY APPLICATION, 2021-2030 (USD Million) TABLE 35. LAMEA MARKET, BY COUNTRY, 2021-2030 (USD Million) TABLE 36. LAMEA MARKET, By Product, 2021-2030 (USD Million) TABLE 37. LAMEA MARKET, By Type, 2021-2030 (USD Million) TABLE 38. LAMEA MARKET, BY APPLICATION, 2021-2030 (USD Million) TABLE 39. Boston Scientific Corporation: COMPANY SNAPSHOT TABLE 40. Boston Scientific Corporation: OPERATING SEGMENTS TABLE 41. Medtronic: COMPANY SNAPSHOT TABLE 42. Medtronic: OPERATING SEGMENTS TABLE 43. Zoll Medical Corporation: COMPANY SNAPSHOT TABLE 44. Zoll Medical Corporation: OPERATING SEGMENTS TABLE 45. MicroPort Scientific Corporation: COMPANY SNAPSHOT TABLE 46. MicroPort Scientific Corporation : OPERATING SEGMENTS TABLE 47. Cook Medical: COMPANY SNAPSHOT TABLE 48. Cook Medical: OPERATING SEGMENTS TABLE 49. BIOTRONIK: COMPANY SNAPSHOT TABLE 50. BIOTRONIK : OPERATING SEGMENTS TABLE 51. MEDICO SpA: COMPANY SNAPSHOT TABLE 52. MEDICO SpA: OPERATING SEGMENTS TABLE 53. Pacetronix: COMPANY SNAPSHOT TABLE 54. Pacetronix: OPERATING SEGMENTS TABLE 55. Oscor Inc.: COMPANY SNAPSHOT TABLE 56. Oscor Inc.: OPERATING SEGMENTS TABLE 57. Osypka Medical GmbH : COMPANY SNAPSHOT TABLE 58. Osypka Medical GmbH : OPERATING SEGMENTS TABLE 59. Lepu Medical : COMPANY SNAPSHOT TABLE 60. Lepu Medical : OPERATING SEGMENTS TABLE 61. LivaNova: COMPANY SNAPSHOT TABLE 62. LivaNova: OPERATING SEGMENTS TABLE 63. Pacetronix: COMPANY SNAPSHOT TABLE 64. Pacetronix: OPERATING SEGMENTS TABLE 65. MEDICO: COMPANY SNAPSHOT TABLE 66. MEDICO: OPERATING SEGMENTS TABLE 67. Osypka Medical: COMPANY SNAPSHOT TABLE 68. Osypka Medical: OPERATING SEGMENTS List of Figures (24 Figures) Figure 1 Market: Research Methodology Steps Figure 2 Research Design Figure 3 Breakdown of Primaries: Market Figure 4 Research Methodology: Hypothesis Building Figure 5 Market: Product-Based Estimation Figure 6 Top 15 Companies with Highest No. Of Patent in Last 9 Years Figure 7 No. Of Patents Granted Per Year, 2019–2021 Figure 8 Import Data for Cardiac Pacemaker, By Country, 2016–2021 (USD Thousand) Figure 9 Export Data for Cardiac Pacemaker, By Country, 2016–2021 (USD Thousand) Figure 10 Data Triangulation Methodology Figure 11 Market, By Type, 2019 vs. 2025 (USD Million) Figure 12 Market Share, By Application, 2019 vs. 2025 (USD Million) Figure 13 Market Share, By Product, 2019 vs. 2025 (USD Million) Figure 14 Market Share, By End-User, 2019 vs. 2025 (USD Million) Figure 15 Geographical Snapshot of the Market Figure 16 Implantable Cardiac Pacemakers to Witness Higher CAGR in Market for Product Segment during Forecast Period. Figure 17 Conventional Pacemakers to Witness Higher CAGR in Market for Type Segment during Forecast Period. Figure 18 Hospitals & Cardiac Centers to Witness Higher CAGR in Market for End-User Segment during Forecast Period. Figure 19 Arrhythmias to Witness Higher CAGR in Market for Applications Segment during Forecast Period. Figure 20 North America Accounted for the Largest Share of the Market, By Regional Basis, in 2019 Figure 21 Market: Drivers, Restraints, Opportunities, and Challenges Figure 22 North America: Market Snapshot Figure 23 Asia Pacific: Market Snapshot Figure 24 Vendor Dive: Evaluation Overview